// App-Quantinova.ai

e13560 : Antitumor activity and suppression of AKT pathway activation by PDK1 inhibitor SNS-391.

Researchers

Presenter

  • Stig K Hansen

Principal Investigators

  • Nuzhat Pathan

  • Lihong Sun

  • Judith Ann Fox

Medical Centers

  • Genomics Institute of the Novartis Research Foundation, San Diego, CA.

  • Biogen Idec, Cambridge, MASunesis Pharmaceuticals, Inc., South San Francisco, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Colorectal Cancer

  • Prostate cancer

  • Melanoma

  • Solid malignancies

Biomarkers

  • Phosphatase and tensin homolog

  • Pyruvate dehydrogenase kinase 1

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Novartis

  • Sunesis Pharmaceuticals

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved